ERBB2 and invasive ductal breast carcinoma: Among the HER2-negative cases, 505 were invasive ductal carcinoma after neoadjuvant therapy, 7 were mucinous adenocarcinoma, and 62 were of undetermined type; 583 were <70 years old, and 10 were ≥70 years old.